LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes
Open Access
- 18 December 2015
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 59 (3) , 634-643
Abstract
Aims/hypothesis Diabetic cardiomyopathy is a myocardial disease triggered by impaired insulin signalling, increased fatty acid uptake and diminished glucose utilisation. Liver X receptors (LXRs) are key transcriptional regulators of metabolic homeostasis. However, their effect in the diabetic heart is largely unknown. Methods We cloned murine Lxrα (also known as Nr1h3) behind the α-myosin heavy chain (αMhc; also known as Myh6) promoter to create transgenic (Lxrα-Tg) mice and transgene-negative littermates (wild-type [WT]). A mouse model of type 2 diabetes was induced by a high-fat diet (HFD, 60% energy from fat) over 16 weeks and compared with a low-fat diet (10% energy from fat). A mouse model of type 1 diabetes was induced via streptozotocin injection over 12 weeks. Results HFD manifested comparable increases in body weight, plasma triacylglycerol and insulin resistance per OGTT in Lxrα-Tg and WT mice. HFD significantly increased left ventricular weight by 21% in WT hearts, but only by 5% in Lxrα-Tg. To elucidate metabolic effects in the heart, microPET (positron emission tomography) imaging revealed that cardiac glucose uptake was increased by 1.4-fold in WT mice on an HFD, but further augmented by 1.7-fold in Lxrα-Tg hearts, in part through 5′ adenosine monophosphate-activated protein kinase (AMPK) phosphorylation and restoration of glucose transporter 4 (GLUT4). By contrast, streptozotocin-induced ablation of insulin signalling diminished cardiac glucose uptake levels and caused cardiac dysfunction, indicating that insulin may be important in LXRα-mediated glucose uptake. Chromatin immunoprecipitation assays identified natriuretic peptides, atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), as potential direct targets of cardiac LXRα overexpression. Conclusions/interpretation Cardiac-specific LXRα overexpression ameliorates the progression of HFD-induced left ventricular hypertrophy in association with increased glucose reliance and natriuretic peptide signalling during the early phase of diabetic cardiomyopathy. These findings implicate a potential protective role for LXR in targeting metabolic disturbances underlying diabetes.Keywords
Funding Information
- Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VIDI, grant number 917.13.350)
This publication has 40 references indexed in Scilit:
- Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial FibrogenesisCirculation: Heart Failure, 2013
- Acute Inhibition of Fatty Acid Import Inhibits GLUT4 Transcription in Adipose Tissue, but Not Skeletal or Cardiac Muscle Tissue, Partly Through Liver X Receptor (LXR) SignalingDiabetes, 2010
- Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathyThe Journal of Physiology, 2009
- Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF- B signallingCardiovascular Research, 2009
- CD36 Expression Contributes to Age-Induced Cardiomyopathy in MiceCirculation, 2007
- Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean andob/obmiceAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic SyndromeHypertension, 2005
- Atrial Natriuretic Peptide Dose-Dependently Inhibits Pressure Overload-Induced Cardiac RemodelingHypertension, 2004
- Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)The American Journal of Cardiology, 1991
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972